359 related articles for article (PubMed ID: 17825579)
1. Soluble HLA-G: Are they clinically relevant?
Pistoia V; Morandi F; Wang X; Ferrone S
Semin Cancer Biol; 2007 Dec; 17(6):469-79. PubMed ID: 17825579
[TBL] [Abstract][Full Text] [Related]
2. Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release.
Morandi F; Levreri I; Bocca P; Galleni B; Raffaghello L; Ferrone S; Prigione I; Pistoia V
Cancer Res; 2007 Jul; 67(13):6433-41. PubMed ID: 17616704
[TBL] [Abstract][Full Text] [Related]
3. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy.
Rizzo R; Andersen AS; Lassen MR; Sørensen HC; Bergholt T; Larsen MH; Melchiorri L; Stignani M; Baricordi OR; Hviid TV
Am J Reprod Immunol; 2009 Nov; 62(5):320-38. PubMed ID: 19811467
[TBL] [Abstract][Full Text] [Related]
4. Impact of blood processing on estimation of soluble HLA-G.
Poláková K; Bandžuchová E; Russ G
Neoplasma; 2011; 58(4):337-42. PubMed ID: 21520991
[TBL] [Abstract][Full Text] [Related]
5. Quantification and identification of soluble HLA-G isoforms.
Rebmann V; LeMaoult J; Rouas-Freiss N; Carosella ED; Grosse-Wilde H
Tissue Antigens; 2007 Apr; 69 Suppl 1():143-9. PubMed ID: 17445190
[TBL] [Abstract][Full Text] [Related]
6. HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms.
Hviid TV; Rizzo R; Christiansen OB; Melchiorri L; Lindhard A; Baricordi OR
Immunogenetics; 2004 Jun; 56(3):135-41. PubMed ID: 15133645
[TBL] [Abstract][Full Text] [Related]
7. Timing of serum soluble HLA-G levels in acute and subacute phases after spontaneous intracerebral hemorrhage.
Fainardi E; Rizzo R; Lupato A; Ramponi V; De Santis G; Garofano F; Stignani M; Tamborino C; Castellazzi M; Casetta I; Baricordi OR
Acta Neurochir Suppl; 2010; 106():141-5. PubMed ID: 19812937
[TBL] [Abstract][Full Text] [Related]
8. Detection of soluble HLA-G molecules in plasma and amniotic fluid.
Rebmann V; Pfeiffer K; Pässler M; Ferrone S; Maier S; Weiss E; Grosse-Wilde H
Tissue Antigens; 1999 Jan; 53(1):14-22. PubMed ID: 10082427
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of the soluble isoforms of HLA-G.
Hunt JS; Pace JL; Morales PJ; Ober C
Mol Hum Reprod; 2003 Nov; 9(11):729-35. PubMed ID: 14561816
[TBL] [Abstract][Full Text] [Related]
10. Secretion of sHLA-G molecules in malignancies.
Rebmann V; Regel J; Stolke D; Grosse-Wilde H
Semin Cancer Biol; 2003 Oct; 13(5):371-7. PubMed ID: 14708717
[TBL] [Abstract][Full Text] [Related]
11. Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease.
Borghi A; Fogli E; Stignani M; Melchiorri L; Altieri E; Baricordi O; Rizzo R; Virgili A
Arch Dermatol Res; 2008 Nov; 300(10):551-9. PubMed ID: 18797896
[TBL] [Abstract][Full Text] [Related]
12. [Expression of human leucocyte antigen G in peripheral blood of kidney transplantation recipients].
Xiao L; Shi BY; Cai M; He XY; Xu XG; Han Y; Zhou WQ; Meng XY; Gao Y
Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(4):241-4. PubMed ID: 20356537
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis.
Fainardi E; Rizzo R; Melchiorri L; Castellazzi M; Paolino E; Tola MR; Granieri E; Baricordi OR
Mult Scler; 2006 Feb; 12(1):2-12. PubMed ID: 16459714
[TBL] [Abstract][Full Text] [Related]
14. HLA-G and lymphoproliferative disorders.
Amiot L; Le Friec G; Sebti Y; Drénou B; Pangault C; Guilloux V; Leleu X; Bernard M; Facon T; Fauchet R
Semin Cancer Biol; 2003 Oct; 13(5):379-85. PubMed ID: 14708718
[TBL] [Abstract][Full Text] [Related]
15. Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004.
Rebmann V; Lemaoult J; Rouas-Freiss N; Carosella ED; Grosse-Wilde H
Hum Immunol; 2005 Aug; 66(8):853-63. PubMed ID: 16216668
[TBL] [Abstract][Full Text] [Related]
16. Maternal antigen presenting cells are a source of plasmatic HLA-G during pregnancy: longitudinal study during pregnancy.
Alegre E; Díaz-Lagares A; Lemaoult J; López-Moratalla N; Carosella ED; González A
Hum Immunol; 2007 Aug; 68(8):661-7. PubMed ID: 17678720
[TBL] [Abstract][Full Text] [Related]
17. [Histocompatibility HLA system of man. Considerations in the light of current concepts. V. sHLA-I in patient's body fluids].
Kedzierska A; Turowski G
Przegl Lek; 2001; 58(9):868-72. PubMed ID: 11868250
[TBL] [Abstract][Full Text] [Related]
18. Soluble HLA-G molecules are increased in lymphoproliferative disorders.
Sebti Y; Le Friec G; Pangault C; Gros F; Drénou B; Guilloux V; Bernard M; Lamy T; Fauchet R; Amiot L
Hum Immunol; 2003 Nov; 64(11):1093-101. PubMed ID: 14602240
[TBL] [Abstract][Full Text] [Related]
19. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.
Contini P; Ghio M; Poggi A; Filaci G; Indiveri F; Ferrone S; Puppo F
Eur J Immunol; 2003 Jan; 33(1):125-34. PubMed ID: 12594841
[TBL] [Abstract][Full Text] [Related]
20. Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways.
Le Rond S; Gonzalez A; Gonzalez AS; Carosella ED; Rouas-Freiss N
Immunology; 2005 Nov; 116(3):297-307. PubMed ID: 16236119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
